title: GM-CSF in the treatment of Felty syndrome.
abstract: Many therapeutic agents have been tried with variable success in the treatment of Felty neutropenia, but the reports are anecdotal. We now describe the second trial of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), in a splenectomized, infected patient with Felty syndrome.
authors.affiliation: Divsion of Hematology/Oncology, James Graham Brown Cancer Center.
authors.forename: G
authors.initials: G
authors.lastname: Joseph
authors.forename: D H
authors.initials: DH
authors.lastname: Neustadt
authors.forename: J
authors.initials: J
authors.lastname: Hamm
authors.forename: M
authors.initials: M
authors.lastname: Kellihan
authors.forename: T
authors.initials: T
authors.lastname: Hadley
mesh_terms: D005258:Felty Syndrome / Q000188:drug therapy*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor